There is no indication for chemotherapy for IPMN as it is considered a premalignant condition. Currently, surgery is the mainstay ofÂ therapy. If an invasive cancer component is identified after surgery then the patient needs adjuvant chemotherapy. The chemotherapy would be gemcitabine, or gemcitabine plus capecitabine or modified FOLFIRINOX for 6 months